US Patent Issued to Sarepta Therapeutics on March 25 for "Processes for preparing phosphorodiamidate morpholino oligomers" (Massachusetts Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,362, issued on March 25, was assigned to Sarepta Therapeutics Inc..

"Processes for preparing phosphorodiamidate morpholino oligomers" was invented by Baozhong Cai (Cambridge, Mass.), Mitchell Martini (Cambridge, Mass.), Ross Shimabuku (Cambridge, Mass.) and Katie Thomas (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are processes for preparing an oligomer (e.g., a morpholino oligomer). The synthetic processes described herein may be advantageous to scaling up oligomersynthesis while maintaining overall yield and purity of a synthesized oligomer."

The patent was filed on Feb. 8, 2021, under Application No. 17/169,6...